ETON insider trading
HealthcareEton Pharmaceuticals, Inc.: insider trade history from SEC Form 4 filings.
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Company website: www.etonpharma.com
ETON insider activity at a glance
FilingIQ tracks 131 insider transactions for ETON in filings since Nov 15, 2018. The most recent transaction is dated Aug 28, 2026.
Across the full history, 29 open-market purchases
and 74 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ETON insider trades is 54.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ETON Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ETON?
- FilingIQ tracks 131 Form 4 insider transactions for ETON (Eton Pharmaceuticals, Inc.), covering filings from Nov 15, 2018 onwards. 22 of those are dated within the last 90 days.
- Are ETON insiders net buyers or net sellers?
- Across the full Form 4 history for ETON, 29 transactions (22%) were open-market purchases and 74 (56%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ETON insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ETON in?
- Eton Pharmaceuticals, Inc. (ETON) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $458.04M.
Methodology & sources
Every ETON insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.